Alpha-Synuclein Expressing Neurons

Alpha-Synuclein Expressing Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Alpha-Synuclein Expressing Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Synuclein Family</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Presynaptic terminals, Lewy bodies</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Alpha-synuclein (SNCA)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Synaptic plasticity, neurotransmitter release</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0004117](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0004117](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)</td>
</tr>
</table>

Introduction

Alpha Synuclein Expressing Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

Alpha-Synuclein Expressing Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Alpha-Synuclein Expressing Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Synuclein Family</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Presynaptic terminals, Lewy bodies</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Alpha-synuclein (SNCA)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Synaptic plasticity, neurotransmitter release</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0004117](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0004117](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)</td>
</tr>
</table>

Introduction

Alpha Synuclein Expressing Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Alpha-synuclein expressing neurons represent a critical population in the study of Parkinson's disease (PD) and related synucleinopathies. These neurons are characterized by the presence of alpha-synuclein (SNCA), a small presynaptic protein that plays essential roles in normal neuronal function but can aggregate into toxic species that drive neurodegeneration. [@cregg2010]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0004117)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)
• [OBO Foundry (CL:0004117)](http://purl.obolibrary.org/obo/CL_0004117)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0004117)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004117)
• [OBO Foundry (CL:0004117)](http://purl.obolibrary.org/obo/CL_0004117)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Normal Physiological Function

Synaptic Vesicle Cycling

Alpha-synuclein is highly enriched in presynaptic terminals where it regulates synaptic vesicle trafficking and neurotransmitter release. Under normal conditions, alpha-synuclein:

• Vesicle preparation: Assists in the clustering of synaptic vesicles at the presynaptic terminal, preparing them for release
• Neurotransmitter release: Modulates the release probability and timing of neurotransmitters including dopamine, glutamate, and GABA
• Synaptic plasticity: Influences both short-term and long-term synaptic plasticity through interactions with synaptic vesicle proteins and the SNARE complex

The protein's N-terminal domain binds to lipid membranes, particularly those of synaptic vesicles, while its C-terminal domain exhibits chaperone-like activity that helps maintain synaptic protein homeostasis.

Membrane Remodeling and Traffic

Alpha-synuclein participates in membrane curvature generation and vesicle dynamics through its lipid-binding N-terminal region. This function is essential for:

• Maintaining synaptic vesicle pools
• Regulating vesicle recycling between the readily releasable pool and the resting pool
• Coordinating endocytosis and exocytosis at the presynaptic terminal

Autophagy and Protein Clearance

The C-terminal region of alpha-synuclein has molecular chaperone activity that helps target misfolded proteins for autophagy-mediated degradation. Normal alpha-synuclein function includes:

• Selective autophagy of damaged mitochondria (mitophagy)
• Lysosomal function maintenance
• Prevention of protein aggregate formation

Pathological Mechanisms in Disease

Aggregation Cascade

In Parkinson's disease and related disorders, alpha-synuclein undergoes a toxic conformational change:

Monomeric alpha-synuclein: Normal soluble protein form

Oligomeric intermediates: Toxic soluble aggregates that disrupt cellular function

Insoluble fibrils:组件 of Lewy bodies and Lewy neurites

The aggregation is seeded by existing pathological forms in a prion-like manner, where misfolded alpha-synuclein can template the conversion of normal protein into the pathogenic form.

Neuronal Vulnerability

Specific neuronal populations are particularly vulnerable to alpha-synuclein pathology:

• Dopaminergic neurons in substantia nigra pars compacta: Primary site of degeneration in PD, with loss of ~50-70% at disease onset
• Cholinergic neurons in basal forebrain: Degeneration contributes to cognitive decline
• Noradrenergic neurons in locus coeruleus: Early involvement in PD progression
• Enteric nervous system neurons: Site of early alpha-synuclein pathology, possibly preceding brain involvement

Mechanisms of Neurodegeneration

Alpha-synuclein pathology drives neuronal death through multiple mechanisms:

• Mitochondrial dysfunction: Direct interaction with mitochondrial proteins, impaired complex I activity
• Oxidative stress: Increased reactive oxygen species production, lipid peroxidation
• ER stress: Disrupted protein folding, activation of unfolded protein response
• Neuroinflammation: Microglial activation through neuron-released alpha-synuclein
• Synaptic dysfunction: Loss of synaptic proteins, impaired neurotransmission
• Axonal transport defects: Disruption of microtubule-based transport

Alpha-Synuclein Expression Patterns

Region-Specific Expression

Alpha-synuclein is expressed throughout the nervous system but shows variable levels:

• Highest expression: Substantia nigra, cerebral cortex, hippocampus
• Moderate expression: Basal ganglia, thalamus, brainstem nuclei
• Lower expression: Spinal cord, peripheral nervous system

Cell Type Specificity

While alpha-synuclein is primarily neuronal, it can also be expressed in:

• Oligodendrocytes (particularly in Multiple System Atrophy)
• Astrocytes (lesser extent)
• Microglia (induced under pathological conditions)

Therapeutic Implications

Disease-Modifying Strategies

Understanding alpha-synuclein expressing neurons has led to several therapeutic approaches:

Anti-aggregation agents: Small molecules designed to prevent alpha-synuclein misfolding

Immunotherapy: Active and passive vaccines targeting alpha-synuclein

Gene therapy: ASO and RNAi approaches to reduce SNCA expression

Neuroprotective agents: Compounds targeting downstream pathways (mitochondrial function, oxidative stress)

Biomarker Development

Alpha-synuclein in cerebrospinal fluid and blood serves as a biomarker:

• Total alpha-synuclein: Decreased in PD due to neuronal loss
• Phosphorylated alpha-synuclein: Increased in synucleinopathies
• Oligomeric alpha-synuclein: Correlates with disease progression

Research Models

Cellular Models

• Induced pluripotent stem cells (iPSCs): Derived from PD patients with SNCA mutations
• Primary neuron cultures: Overexpression or knockdown models
• Alpha-synuclein preformed fibril (PFF) models: Seeding pathology in healthy neurons

Animal Models

• Transgenic mice: SNCA overexpression under various promoters
• Knockin models: Humanized alpha-synuclein with mutations
• Viral vector models: AAV-mediated SNCA overexpression
• [Alpha-Synuclein](/proteins/alpha-synuclein) [Parkinson's Disease](/diseases/parkinsons-disease)
• [Lewy Body Dementia](/diseases/lewy-body-dementia)
• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• Substantia Nigra
• Dopaminergic Neurons
• Mitoc- [Neuroinflammation](/mechanisms/neuroinflammation)n in PD
• [Neuroinflammation](/mechanisms/neuroinflammation)

Background

The study of Alpha Synuclein Expressing Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Michael J. Fox Foundation - Alpha-Synuclein Research](https://www.michaeljfox.org)
• [Parkinson's Foundation](https://www.parkinson.org)
• [Lewy Body Dementia Association](https://www.lbda.org)
• [NIH Parkinson's Disease Information Page](https://www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-Disease-Information-Page)

Pathway Diagram

The following diagram shows the key molecular relationships involving Alpha-Synuclein Expressing Neurons discovered through SciDEX knowledge graph analysis: